Search Results
Filter Results:
People (1205)
Demian Ahn
Partner
Demian Ahn is a member of the firm’s data, privacy, and cybersecurity practice based in Washington, D.C. He leads the firm’s incident response practice and advises companies on compliance, regulatory, and crisis management matters relating to emerging technologies of all kinds.
Josephine Aiello LeBeau
Partner
Josephine focuses on matters related to compliance and enforcement of U.S. export control and sanctions.
Ali R. Alemozafar
Partner
Ali counsels clients on patent strategy, prosecution, and diligence for financings, M&A, and IPOs.
Lester Ang
Partner
Lester Ang is a corporate and securities partner in the Palo Alto office of Wilson Sonsini, where he works with private and public technology and life sciences companies through all stages of their growth, as well as with venture capital firms and private equity firms.
Brian Appel
Partner
Brian Appel is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.
Matthew A. Argenti
Partner
Matt is an experienced patent litigatior with an focus on post-grant review proceedings before the PTAB.
Hin Au
Partner
Hin Au is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Hin provides IP strategy and counseling services to clients in a wide range of technical fields, including MedTech, digital health, biotech, medical/diagnostic devices, software, robotics, autonomous vehicle technologies, and clean energy. He has assisted many clients with building their patent portfolios and securing key strategic patents. Hin has hands-on engineering industry experience, having previously worked as an R&D engineer for six years at large U.S. semiconductor corporations. A native of Singapore, Hin is also fluent in Mandarin and Cantonese.
Christine K. Au-Yeung
Partner
Christine Au-Yeung is a partner in the San Francisco and Palo Alto offices of Wilson Sonsini Goodrich & Rosati, where she focuses on trademark, copyright, and advertising law. She counsels clients on all aspects of brand protection in the U.S. and throughout the world, including clearance and selection of trademarks, prosecution of trademark applications, licensing, and the resolution of trademark infringement and domain name disputes. She also advises clients on advertising issues, including TCPA compliance related to marketing calls and texts, as well as strategies on promotions such as sweepstakes and contests.
Megan J. Baier
Partner
Megan Baier has spent her career advising founders, boards, and public companies through the moments that define them: first financings, public offerings, and the governance decisions that follow. A partner in Wilson Sonsini's New York corporate group, she combines deep technical command of securities law with the judgment and steadiness clients need when the stakes are high.
Services (113)
Insights (4827)
Alerts
7.10.26
The FTC After Slaughter: What Businesses Need to Understand
On June 29, 2026, the U.S. Supreme Court issued its opinion in Trump v. Slaughter, where the six-Justice majority held that appointed agency officials who wield executive power are subject to presidential removal. In so holding, the Court overruled its 1935 decision in Humphrey’s Executor v. United States, 295 U.S. 602 (1935), which for nearly a century stood for the principle that Congress can create independent agencies whose leaders can only be removed for cause.
Client Highlights
7.09.26
Wilson Sonsini Advises Beam Benefits on Acquisition by Principal Financial Group
On July 7, 2026, Principal Financial Group announced an agreement to acquire Beam Benefits, an employee benefits company serving more than 25,000 small businesses. Principal currently serves 180,000 employers, providing comprehensive retirement, benefits, and business owner solutions. The acquisition is expected to close in the latter half of 2026, subject to the completion of customary closing conditions and regulatory approvals. Wilson Sonsini Goodrich & Rosati advised Beam Benefits on the transaction.
Client Highlights
7.09.26
Wilson Sonsini Advises Standard Bots on $200 Million Series C
On June 11, 2026, Standard Bots, the largest manufacturer of AI-native, industrial robotics in the United States, announced a $200 million Series C led by RoboStrategy and existing investors, valuing the company at $1 billion. Standard Bots is also expanding its manufacturing footprint in New York, increasing its ability to design, assemble, and deploy American-made robots at scale. Wilson Sonsini Goodrich & Rosati advised Standard Bots on the transaction.
Alerts
7.08.26
SCOTUS Ruling Calls into Question EU-U.S. Personal Data Flows
On June 29, 2026, the Supreme Court of the U.S. (SCOTUS) held in Trump v. Slaughter that the U.S. President can dismiss members of the Federal Trade Commission (FTC) at will, rather than only for cause, overruling existing precedent regarding independent agencies. This decision of domestic constitutional law could also change the rules governing transfer of personal data from the European Economic Area (EEA, which includes the 27 European Union countries plus Iceland, Liechtenstein, and Norway) to the U.S.
Client Highlights
7.08.26
Wilson Sonsini Advises Arca on $64 Million Series A
On June 24, 2026, Arca Wealth (Arca), an AI-native wealth management company that brings personalized, advisor-led financial services, exited stealth and announced it secured $64 million across its seed round and Series A. The $48.5 million Series A was led by General Catalyst, with strong backing from Index Ventures and Venrock. Venrock also led the company's $15.5 million seed round. Wilson Sonsini Goodrich & Rosati advised Arca on the transaction.
Client Highlights
7.08.26
Wilson Sonsini Advises Crinetics on Patent Matters Related to $10 Billion Acquisition by Vertex
On July 6, 2026, Vertex Pharmaceuticals and Crinetics Pharmaceuticals, a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases, announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10 billion, or approximately $8.8 billion net of estimated cash acquired. Wilson Sonsini Goodrich & Rosati is patent counsel to Crinetics and advised the company on patent matters related to the transaction.
Client Highlights
7.08.26
Wilson Sonsini Advises Insilico on Collaboration with Takeda
On July 1, 2026, Insilico Medicine (Insilico), a clinical-stage biotechnology company powered by generative artificial intelligence and automation, announced a strategic collaboration agreement with Takeda to use Insilico’s proprietary end-to-end platform, Pharma.AI, to advance drug candidates across various therapeutic areas, with a potential initial value of $600 million. Insilico will lead drug discovery, while Takeda will further development, including advancing candidates past clinical trials.
Client Highlights
7.08.26
Wilson Sonsini Advises Monogram on $40 Million Seed Round as Company Emerges from Stealth
On July 7, 2026, Monogram, a developer of an artificial intelligence (AI) application built around visual interface, emerged from stealth and announced a $40 million seed round led by DST Global and Lux Capital. Wilson Sonsini Goodrich & Rosati advised Monogram on the transaction.
Client Highlights
7.08.26
Wilson Sonsini Advises TwelveLabs on $100 Million Series B
On July 1, 2026, TwelveLabs, a leading video intelligence company, announced it has raised $100 million in Series B funding. The round was co-led by NEA and NAVER Ventures with participation from Amazon, Radical Ventures, Korea Investment Partners, Index Ventures, Quadrille Capital, and Red Bull Ventures. Wilson Sonsini Goodrich & Rosati advised TwelveLabs on the transaction.
Events (1822)
Affiliated Programs
10.20.26
East Coast NextGen VC Forum 2026
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Affiliated Programs
9.15.26
West Coast NextGen VC Forum
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Affiliated Programs
7.22.26
WIB-San Francisco Bay Area & PBSS: Symposium on the Advances in the Development of Therapeutics and Diagnostics for Women’s Health
PBSS is teaming up with Women in Bio (WIB) to host a virtual symposium focused on therapies and diagnostics for women’s health. You’ll hear from other speakers in industry, academia, and non-profit research organizations on their experience raising funding, setting new healthcare standards, and advocating for women’s health. Sara Kenkare-Mitra, formerly at Genentech and Alector, will give a plenary talk followed by panelists from the Gates Foundation, the Buck Institute, and industry experts. At the end of the symposium, there will be a panel for deeper conversations on the successes and current challenges in this space. This is a free industry event; register today.
Affiliated Programs
7.15.26
Compensation Confidential 2026: Preparing for Investors and Scaling Your Team
Wilson Sonsini is proud to support LaunchBio’s Beyond the Pitch webinar series. We invite you to tune in for Compensation Confidential 2026, a dedicated webinar designed for industry leaders, emerging entrepreneurs, and professionals navigating today's talent landscape.
Speaking Engagements
7.16.26
Milestone Summit 2026
More than 200 founders, investors, and cultural and civic leaders from across the country and around the world will gather in Seattle, WA, for the Nasdaq Entrepreneurial Center’s Milestone Summit 2026. From capital access to creative economy, from founder resilience to global impact, this two-day program offers interactive panels and educational workshops to help attendees create real momentum for the milestones ahead.
WSGR Events
7.16.26
Navigating the Corporate Practice of Medicine: Compliance Essentials and Recent Developments
The corporate practice of medicine (CPOM) doctrine restricts the ability of non-physician entities to employ or engage physicians or direct the practice of medicine in certain states. The CPOM doctrine’s rules, which are anything but uniform, make it a threshold issue for any digital health company with a care delivery component. Join Wilson Sonsini for its semi-annual training for digital health executives, designed to keep them current on both the fundamentals and the latest developments shaping CPOM compliance. Each session addresses the core framework and spotlights what has changed since the last installment, so your team can stay ahead of the fast-moving regulatory landscape.
Affiliated Programs
7.09.26
NASDAQ International Go-To-Market Bootcamp 2026
Wilson Sonsini invites you to the third Bootcamp co-hosted by the Nasdaq Entrepreneurial Center and KPMG. Executive Advisor Ken Siegel and industry leaders will share practical guidance and proven strategies for navigating global markets.